Role of Interrupting Sedentary Time in Management of Type-2 Diabetes
Just_StandUp
Investigating the Response of Glycaemic Excursions in Type-2 Diabetes to Interrupting Prolonged Sedentary Behaviour (Sitting)
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
Type-2 diabetes, a common non-infectious disease, is the result of impaired insulin function and insulin production in the body. In type-2 diabetic patients, postprandial glucose control, lipid control and reduction of insulin resistance are crucial to deter the development of diabetes related complications (e.g. retinopathy, nephropathy, neuropathy and cardiovascular diseases), pancreatic β cells failure, morbidity and mortality. Currently, diet, exercise and standard oral medicines are used to treat type-2 diabetes. However, providing the most effective treatment to control postprandial glucose and lipid; and to preserve the pancreatic β cells is challenging because poor metabolic profiles are still detected in type-2 diabetic patients. Therefore, understanding the factors influencing the poor metabolic profiles and adjunct therapy to manage type-2 diabetes are really important to tackle this disease. In modern society, people are spending most of their waking time in sedentary behaviour, which is primarily prolonged sitting. Prolonged sedentary time is associated with increased postprandial glucose, lipid and insulin resistance. In contrast, frequent interruption of prolonged sitting with short light activity break reduces postprandial glucose, triglyceride cholesterol and insulin resistance. However, how frequently patients should interrupt sitting, potential longer-term effect of short activity break on reduction of postprandial glucose, triglyceride cholesterol and insulin resistance, and the knowledge, beliefs and experiences on the use of technology to decrease sedentary behaviour and improve glycaemic control are not investigated in type-2 diabetic patients. Therefore, it would be relevant to investigate this to prove the therapeutic role of frequent short activity break in sedentary time in the management of type-2 diabetes. Primary Research Objective:
- 1.To investigate the dose-response effect of frequency/number of light intensity walking breaks of sitting on postprandial glucose, insulin, C-peptide and triglyceride cholesterol level.
- 2.To investigate the potential longer-term effect of light intensity walking breaks of sitting on glucose control using 24-h glucose data.
- 3.To obtain data to inform the development of a future feasibility trial investigating the feasibility, compliance, adherence and longer-term effect of different frequencies of light intensity walking breaks in sitting time on glycaemic excursions in free-living.
- 4.To explore the knowledge, beliefs and experiences of those with Type 2 diabetes on the use of technology to decrease sedentary behaviour and improve glycaemic control, that could be used in the feasibility trial
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes
Started May 2016
Shorter than P25 for not_applicable diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2016
CompletedFirst Posted
Study publicly available on registry
April 14, 2016
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedApril 14, 2016
March 1, 2016
8 months
March 30, 2016
April 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial glucose excursions measured with Area under curve
Dose-response relationship between frequencies of short light activity breaks in sedentary time and postprandial glucose excursions
8 hours
Secondary Outcomes (3)
24 hours glucose profile measured with continuous glucose monitor LifeStyle Libre
24 hours
Insulin, C-peptide and triglyceride cholesterol plasma level during the intervention measured with Area under curve
8 hours
Qualitative exploration of the knowledge, beliefs and experiences of those with type 2 diabetes on the use of technology to decrease sedentary behaviour and improve glycaemic control
1 hour
Study Arms (6)
60-30 min
EXPERIMENTALSitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 60 min and 30 min
30-15 min
EXPERIMENTALSitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 30 min and 15 min
15-60 min
EXPERIMENTALSitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 15 min and 60 min
60-15
EXPERIMENTALSitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 60 min and 15 min
30-60 min
EXPERIMENTALSitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 30 min and 60 min
15-30 min
EXPERIMENTALSitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 15 min and 30 min
Interventions
Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 60 min
Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 30 min
Sitting for 8 hours interrupted by 3 min of light intensity walking (LIW, 3.2 km/h) breaks every 15 min
Eligibility Criteria
You may qualify if:
- Individuals with type 2 diabetes for less than 10 years
- Individuals aged 35-60 years
- Individuals receiving metformin or diet control
- Non-smokers
- Overweight and obese individuals (BMI 25-35 kg/m2)
- Individuals with an HbA1c between \>7%
- Individuals with BP below 160/90mmHg
You may not qualify if:
- Individuals unable or unwilling to consent
- Individuals under the age of 35 years and over the age of 60 years at study enrolment
- Patients on sulphonylurea or other oral hypoglycaemic drugs therapy except metformin
- Individuals with hepatic or renal dysfunction
- Individuals with body mass index greater than 35
- Individuals suffering from cancer, cardiovascular diseases, cirrhosis, hepatitis and renal disease
- Pregnant Individuals
- Individuals who smoke
- Individuals who are alcohol and drug abusers
- Individuals with a blood pressure ≥160/90mmHg
- Individuals diagnosed with anaemia (Hb\<12g/dl in women and \<13 g/dl in men)
- Individuals taking medicines which can interfere with the glucose metabolism (e.g. anticoagulants, oral contraceptives, steroid, thiazide, β-blocker, NSAID, anti-fungal, hormonal therapy, psychotropic drugs)
- Individual taking drugs for glycaemic control in excess of standard care highlighted by the SIGN guideline 116.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Glasgow Caledonian Universitylead
- University of Strathclydecollaborator
Related Publications (9)
Chastin SF, Egerton T, Leask C, Stamatakis E. Meta-analysis of the relationship between breaks in sedentary behavior and cardiometabolic health. Obesity (Silver Spring). 2015 Sep;23(9):1800-10. doi: 10.1002/oby.21180.
PMID: 26308477BACKGROUNDCooper AR, Sebire S, Montgomery AA, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Dayan CM, Andrews RC. Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia. 2012 Mar;55(3):589-99. doi: 10.1007/s00125-011-2408-x. Epub 2011 Dec 14.
PMID: 22167127BACKGROUNDDempsey, P.C., Owen, N., Larsen, R., Straznicky, N., Cohen, Neale., FACSM, B.B., Kingwell, B.A., Dunstan, D.W., Baker IDI Heart and Diabetes Institute, Melbourne, Australia., Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado, USA. 2015. Interrupting Prolonged Sitting: A Potential Therapeutic Tool in the Management of Type 2 Diabetes
BACKGROUNDDunstan DW, Kingwell BA, Larsen R, Healy GN, Cerin E, Hamilton MT, Shaw JE, Bertovic DA, Zimmet PZ, Salmon J, Owen N. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012 May;35(5):976-83. doi: 10.2337/dc11-1931. Epub 2012 Feb 28.
PMID: 22374636BACKGROUNDHealy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, Owen N. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care. 2008 Apr;31(4):661-6. doi: 10.2337/dc07-2046. Epub 2008 Feb 5.
PMID: 18252901BACKGROUNDHenson J, Yates T, Biddle SJ, Edwardson CL, Khunti K, Wilmot EG, Gray LJ, Gorely T, Nimmo MA, Davies MJ. Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia. 2013 May;56(5):1012-20. doi: 10.1007/s00125-013-2845-9. Epub 2013 Mar 1.
PMID: 23456209BACKGROUNDLatouche C, Jowett JB, Carey AL, Bertovic DA, Owen N, Dunstan DW, Kingwell BA. Effects of breaking up prolonged sitting on skeletal muscle gene expression. J Appl Physiol (1985). 2013 Feb 15;114(4):453-60. doi: 10.1152/japplphysiol.00978.2012. Epub 2012 Dec 27.
PMID: 23271697BACKGROUNDPeddie MC, Bone JL, Rehrer NJ, Skeaff CM, Gray AR, Perry TL. Breaking prolonged sitting reduces postprandial glycemia in healthy, normal-weight adults: a randomized crossover trial. Am J Clin Nutr. 2013 Aug;98(2):358-66. doi: 10.3945/ajcn.112.051763. Epub 2013 Jun 26.
PMID: 23803893BACKGROUNDPaing AC, McMillan KA, Kirk AF, Collier A, Hewitt A, Chastin SFM. Dose-response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes. Diabet Med. 2019 Mar;36(3):376-382. doi: 10.1111/dme.13829. Epub 2018 Oct 12.
PMID: 30264906DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Collier,, MBchb
Glasgow Caledonian University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2016
First Posted
April 14, 2016
Study Start
May 1, 2016
Primary Completion
January 1, 2017
Study Completion
April 1, 2017
Last Updated
April 14, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will not share